Patient Navigator Plus Remote Mobile Health Adherence Support with Incentives to Improve Linkage and Retention Among Hospitalized Patients with Opioid and Methamphetamine Use Who Initiate Buprenorphine (Aim 2), Washington, 2019-2021

This data is part of a retrospective, observational study of patients
hospitalized in Washington State and initiated on buprenorphine or Methadone from 05-2019 to 12-2021. Researchers aimed to examine 1) healthcare utilization
outcomes (ED visits and hospital readmission) at 30-, 90- and 180-days
post-discharge and 2) the associations between baseline MA use and healthcare
utilization.

本数据集为一项回顾性观察性研究的组成部分，该研究纳入了2019年5月至2021年12月期间在华盛顿州住院且起始使用丁丙诺啡（buprenorphine）或美沙酮（Methadone）治疗的患者。研究人员旨在开展两项核心研究：其一为分析患者出院后30天、90天及180天的医疗服务利用结局，即急诊就诊（ED）与医院再入院情况；其二为探究基线美沙酮使用情况与医疗服务利用之间的关联。